[Immunomodulation as innovative therapy for head and neck tumors : Current developments].

Area of Science:

• Oncology
• Immunology
• Cancer Research

Background:

• Head and neck squamous cell carcinoma (HNSCC) is known for its potent immune suppression.
• HNSCC possesses complex immune escape mechanisms, contributing to poor patient outcomes.
• Current survival rates for HNSCC remain low, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

• To investigate the potential of immunotherapy in managing HNSCC.
• To focus on antibody-based immune checkpoint modulation as a therapeutic approach.
• To explore the application of immunotherapy in curative settings and for preventing disease recurrence.

Main Methods:

• Review of current clinical studies focusing on immunotherapy in HNSCC.
• Analysis of antibody-based immune checkpoint modulation strategies.
• Evaluation of immunotherapy's role in curative and preventative contexts.

Main Results:

• Immunotherapy is increasingly important for HNSCC treatment.
• Clinical studies are shifting towards antibody-based immune checkpoint modulation.
• The application of immunotherapy in curative or preventative settings is a key research focus.

Conclusions:

• Immunotherapy holds significant promise for improving HNSCC outcomes.
• Targeting immune checkpoints with antibodies is a key strategy.
• Further research is needed to establish immunotherapy's role in HNSCC cure and prevention.